In the last 12 months, insiders at Fortress Biotech, Inc. ($FBIO) filed 56 transactions with the SEC: 9 open-market purchases totaling $1,688,567 and 2 sales totaling $147,900. Net insider sentiment: net buying.
Fortress Biotech, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Fortress Biotech, Inc. (Not found) — 10 transactions totaling $25,230,221
- ROSENWALD LINDSAY A MD (PRESIDENT, CEO & CHAIRMAN) — 4 transactions totaling $1,404,581
- ROSENWALD LINDSAY A MD (President, CEO & Chairman) — 7 transactions totaling $280,236
- Jin David (Chief Financial Officer) — 7 transactions totaling $27,055
- Klein Dov (Director) — 2 transactions totaling $18,900
View all SEC Filings for Fortress Biotech, Inc. (FBIO).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Jin David | Chief Financial Officer | A | Common Stock, par value $0.001 | 2967 | $2.18 | 1,251,571.0000 | 33,100,961 | 0.24% | 0.01% |
| March 18, 2026 | WEISS MICHAEL S | Executive Vice Chairman | A | common stock, par value $0.001 | 475424 | $0.00 | 2,276,562.0000 | 33,100,961 | 26.40% | 1.44% |
| March 18, 2026 | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | A | Common stock, par value $0.001 | 475424 | $0.00 | 4,586,841.0000 | 33,100,961 | 11.56% | 1.44% |
| Jan. 2, 2026 | Fortress Biotech, Inc. | Not found | A | COMMON STOCK, PAR VALUE $0.0001 | 111209 | $0.00 | 439,733.0000 | 33,100,961 | 33.85% | 0.34% |
| Jan. 1, 2026 | Harvey Jimmie | Not found | A | common stock, par value $0.001 | 27322 | $0.00 | 146,704.0000 | 33,100,961 | 22.89% | 0.08% |
| Jan. 1, 2026 | Klein Dov | Not found | A | common stock, par value $0.001 | 27322 | $0.00 | 130,105.0000 | 33,100,961 | 26.58% | 0.08% |
| Jan. 1, 2026 | Lorenz Kevin | Not found | A | common stock, par value $0.001 | 27322 | $0.00 | 101,009.0000 | 33,100,961 | 37.08% | 0.08% |
| Jan. 1, 2026 | LOBELL J JAY | Not found | A | common stock, par value $0.001 | 27322 | $0.00 | 192,397.0000 | 33,100,961 | 16.55% | 0.08% |
| Jan. 1, 2026 | Hoenlein Malcolm | Not found | A | Common Stock, par value $0.001 | 27322 | $0.00 | 115,747.0000 | 33,100,961 | 30.90% | 0.08% |
| Jan. 2, 2026 | Fortress Biotech, Inc. | Not found | A | COMMON STOCK, PAR VALUE $0.0001 | 278385 | $0.00 | 536,577.0000 | 33,100,961 | 107.82% | 0.84% |
| Oct. 1, 2025 | Jin David | Chief Financial Officer | A | Common Stock, par value $0.001 | 2711 | $1.31 | 1,248,604.0000 | 33,100,961 | 0.22% | 0.01% |
| May 30, 2025 | Fortress Biotech, Inc. | Not found | D | COMMON STOCK, PAR VALUE $0.0001 | 6122249 | $4.10 | 0.0000 | 26,450,218 | 100.00% | 23.15% |
| May 30, 2025 | Fortress Biotech, Inc. | Not found | D | CLASS A COMMON STOCK, PAR VALUE $0.0001 | 700000 | $0.00 | 0.0000 | 26,450,218 | 100.00% | 2.65% |
| May 29, 2025 | Fortress Biotech, Inc. | Not found | S | COMMON STOCK, PAR VALUE $0.0001 | 100000 | $1.29 | 6,122,249.0000 | 26,450,218 | 1.61% | 0.38% |
| March 31, 2025 | Fortress Biotech, Inc. | Not found | A | COMMON STOCK, PAR VALUE $0.0001 | 67806 | $0.00 | 198,858.0000 | 20,784,334 | 51.74% | 0.33% |
| April 1, 2025 | Jin David | Chief Financial Officer | A | Common Stock, par value $0.001 | 5000 | $1.22 | 1,245,893.0000 | 26,450,218 | 0.40% | 0.02% |
| Feb. 26, 2025 | Fortress Biotech, Inc. | Not found | A | COMMON STOCK, PAR VALUE $0.0001 | 18500 | $0.00 | 6,222,249.0000 | 20,784,334 | 0.30% | 0.09% |
| Jan. 1, 2025 | WEISS MICHAEL S | Executive Vice Chairman | A | common stock, par value $0.001 | 454153 | $0.00 | 1,801,138.0000 | 20,784,334 | 33.72% | 2.19% |
| Jan. 1, 2025 | LOBELL J JAY | Not found | A | common stock, par value $0.001 | 49383 | $0.00 | 165,075.0000 | 20,784,334 | 42.68% | 0.24% |
| Jan. 1, 2025 | Klein Dov | Not found | A | common stock, par value $0.001 | 49383 | $0.00 | 102,783.0000 | 20,784,334 | 92.48% | 0.24% |
| Jan. 1, 2025 | Lu Lucy | Not found | A | common stock, par value $0.001 | 49383 | $0.00 | 61,273.0000 | 20,784,334 | 415.33% | 0.24% |
| Jan. 1, 2025 | Harvey Jimmie | Not found | A | common stock, par value $0.001 | 49383 | $0.00 | 119,382.0000 | 20,784,334 | 70.55% | 0.24% |
| Jan. 1, 2025 | Lorenz Kevin | Not found | A | common stock, par value $0.001 | 49383 | $0.00 | 73,687.0000 | 20,784,334 | 203.19% | 0.24% |
| Jan. 1, 2025 | Hoenlein Malcolm | Not found | A | Common Stock, par value $0.001 | 49383 | $0.00 | 88,425.0000 | 20,784,334 | 126.49% | 0.24% |
| Dec. 31, 2024 | Fortress Biotech, Inc. | Not found | A | COMMON STOCK, PAR VALUE $0.0001 | 81407 | $0.00 | 3,816,941.0000 | 19,697,290 | 2.18% | 0.41% |
| Jan. 1, 2025 | Fortress Biotech, Inc. | Not found | A | COMMON STOCK, PAR VALUE $0.0001 | 2386808 | $0.00 | 6,203,749.0000 | 20,784,334 | 62.53% | 11.48% |
| Jan. 1, 2025 | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | A | Common stock, par value $0.001 | 454153 | $0.00 | 4,111,417.0000 | 20,784,334 | 12.42% | 2.19% |
| Dec. 19, 2024 | Jin David | Chief Financial Officer | A | Common Stock, par value $0.001 | 1000000 | $0.00 | 1,240,893.0000 | 19,697,290 | 415.12% | 5.08% |
| Oct. 1, 2024 | Jin David | Chief Financial Officer | A | Common Stock, par value $0.001 | 2625 | $1.23 | 240,893.0000 | 19,697,290 | 1.10% | 0.01% |
| Sept. 27, 2024 | Fortress Biotech, Inc. | Not found | A | COMMON STOCK, PAR VALUE $0.0001 | 146341 | $0.00 | 3,735,534.0000 | 18,316,874 | 4.08% | 0.80% |
| Sept. 23, 2024 | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | P | Common stock, par value $0.001 | 763359 | $1.84 | 3,657,264.0000 | 18,316,874 | 26.38% | 4.17% |
| Sept. 23, 2024 | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | P | Warrants to Purchase Common Stock | 763359 | $0.13 | 763,359.0000 | 18,316,874 | 9999.99% | 4.17% |
| July 11, 2024 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | P | SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | 5000 | $7.48 | 127,500.0000 | 18,316,874 | 4.08% | 0.03% |
| July 10, 2024 | Jin David | Chief Financial Officer | P | SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | 500 | $7.50 | 500.0000 | 18,316,874 | 9999.99% | 0.00% |
| July 9, 2024 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | P | SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | 5000 | $7.39 | 122,500.0000 | 18,316,874 | 4.26% | 0.03% |
| July 8, 2024 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | P | SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | 5000 | $7.35 | 117,500.0000 | 18,316,874 | 4.44% | 0.03% |
| June 28, 2024 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | P | COMMON STOCK, PAR VALUE $0.001 | 20000 | $1.64 | 2,893,905.0000 | 17,151,945 | 0.70% | 0.12% |
| June 27, 2024 | Fortress Biotech, Inc. | TenPercentOwner | A | COMMON STOCK, PAR VALUE $0.0001 | 575191 | $0.00 | 2,502,991.0000 | 17,151,945 | 29.84% | 3.35% |
| May 16, 2024 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | P | COMMON STOCK, PAR VALUE $0.001 | 10000 | $1.76 | 2,873,905.0000 | 17,151,945 | 0.35% | 0.06% |
| May 20, 2024 | Klein Dov | Director | S | COMMON STOCK, PAR VALUE $0.001 | 10000 | $1.89 | 53,400.0000 | 17,151,945 | 15.77% | 0.06% |
| April 16, 2024 | Fortress Biotech, Inc. | TenPercentOwner | A | COMMON STOCK, PAR VALUE $0.0001 | 413507 | $0.00 | 3,547,393.0000 | 17,151,945 | 13.19% | 2.41% |
| April 1, 2024 | Jin David | Chief Financial Officer | A | COMMON STOCK, PAR VALUE $0.001 | 2352 | $1.70 | 238,268.0000 | 17,151,945 | 1.00% | 0.01% |
| March 20, 2024 | Fortress Biotech, Inc. | TenPercentOwner | A | COMMON STOCK, PAR VALUE $0.0001 | 193905 | $0.00 | 2,096,278.0000 | 8,110,906 | 10.19% | 2.39% |
| Jan. 5, 2024 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | P | COMMON STOCK, PAR VALUE $0.001 | 50000 | $2.38 | 2,863,905.0000 | 8,110,906 | 1.78% | 0.62% |
| Jan. 2, 2024 | Fortress Biotech, Inc. | TenPercentOwner | A | COMMON STOCK, PAR VALUE $0.0001 | 2101496 | $0.00 | 3,133,886.0000 | 8,110,906 | 203.56% | 25.91% |
| Jan. 1, 2024 | WEISS MICHAEL S | See Remarks | A | COMMON STOCK, PAR VALUE $0.001 | 216465 | $0.00 | 1,346,985.0000 | 8,110,906 | 19.15% | 2.67% |
| Jan. 1, 2024 | Harvey Jimmie | Director | A | COMMON STOCK, PAR VALUE $0.001 | 6666 | $0.00 | 69,999.0000 | 8,110,906 | 10.53% | 0.08% |
| Jan. 1, 2024 | Hoenlein Malcolm | Director | A | COMMON STOCK, PAR VALUE $0.001 | 3333 | $0.00 | 39,042.0000 | 8,110,906 | 9.33% | 0.04% |
| Jan. 1, 2024 | Rowinsky Eric K | Director | A | COMMON STOCK, PAR VALUE $0.001 | 6666 | $0.00 | 68,797.0000 | 8,110,906 | 10.73% | 0.08% |
| Jan. 1, 2024 | LOBELL J JAY | Director | A | COMMON STOCK, PAR VALUE $0.001 | 6666 | $0.00 | 115,692.0000 | 8,110,906 | 6.11% | 0.08% |
| Jan. 1, 2024 | Lorenz Kevin | Director | A | COMMON STOCK, PAR VALUE $0.001 | 3333 | $0.00 | 24,970.0000 | 8,110,906 | 15.40% | 0.04% |
| Jan. 1, 2024 | Lu Lucy | Director | A | COMMON STOCK, PAR VALUE $0.001 | 3333 | $0.00 | 11,890.0000 | 8,110,906 | 38.95% | 0.04% |
| Jan. 1, 2024 | Klein Dov | Director | A | COMMON STOCK, PAR VALUE $0.001 | 6666 | $0.00 | 63,400.0000 | 8,110,906 | 11.75% | 0.08% |
| Jan. 1, 2024 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | A | COMMON STOCK, PAR VALUE $0.001 | 216465 | $0.00 | 2,813,905.0000 | 8,110,906 | 8.33% | 2.67% |
| Jan. 2, 2024 | Fortress Biotech, Inc. | TenPercentOwner | A | COMMON STOCK, PAR VALUE $0.0001 | 419092 | $0.00 | 1,927,800.0000 | 8,110,906 | 27.78% | 5.17% |
| Dec. 29, 2023 | Fortress Biotech, Inc. | TenPercentOwner | A | COMMON STOCK, PAR VALUE $0.0001 | 158134 | $0.00 | 1,902,373.0000 | 7,498,653 | 9.07% | 2.11% |